CRISPR-targeting introduced a DLL1 variant whose predicted amino acids of the MNNL and DSL domains that contact N1 are replaced with the corresponding amino acids of DLL4. Cre-mediated recombination removed the floxed neomycin resistance cassette. (J:274018)